Literature DB >> 22981957

Excluded, not dismissed: enhancing benefit in clinical research.

Maria Nardell1, Akansha Chhabra, Lubna Pal.   

Abstract

Participation in clinical research projects may allow an opportunity for early detection of covert diseases and subclinical disorders in asymptomatic volunteers from study-specific screening process. Exclusion of a potential participant due to failure to meet inclusion criteria eliminates any possibility of potential for research related benefit, as may exist for those that are deemed eligible and allowed to proceed with participation in the specific research study. Although the institutional bodies overseeing conduct of clinical research strive to ensure an ongoing scrutiny and prioritization of participants' wellbeing, we perceive that these mechanisms fall short as regards the interests of those volunteers who are subsequently excluded from participation in clinical research of relevance. While provision of ancillary care to address health concerns that are unmasked during the screening process may be an optimal strategy, the likelihood of successfully implementing this latter concept in current times of fiscal constraints is slim to nonexistent. Through this submission, we hope to initiate a dialogue within the research community regarding whether the current paradigm of conduct of clinical research be modified to include some degree of consideration for the screened out. We herein propose that for those volunteering for disease/disorder specific clinical research, some added degree of benefit can be assured to the screened out population through the provision of targeted health education or counseling.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22981957      PMCID: PMC3525712          DOI: 10.1016/j.cct.2012.08.013

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  13 in total

Review 1.  Ethical issues in the conduct of research at a multidisciplinary clinic.

Authors:  Jennifer Larsen; Andy McMillin
Journal:  Semin Speech Lang       Date:  2011-12-05       Impact factor: 1.761

2.  Women's perceptions of polycystic ovary syndrome following participation in a clinical research study: implications for knowledge, feelings, and daily health practices.

Authors:  Katie Colwell; Marla E Lujan; Karen L Lawson; Roger A Pierson; Donna R Chizen
Journal:  J Obstet Gynaecol Can       Date:  2010-05

3.  Clinical ethics versus clinical research.

Authors:  Paul S Appelbaum; Charles W Lidz
Journal:  Am J Bioeth       Date:  2006 Jul-Aug       Impact factor: 11.229

4.  Knowing your risk factors for coronary heart disease improves adherence to advice on lifestyle changes and medication.

Authors:  Carin Alm-Roijer; Bengt Fridlund; Martin Stagmo; Leif Erhardt
Journal:  J Cardiovasc Nurs       Date:  2006 Sep-Oct       Impact factor: 2.083

5.  The limitations of "vulnerability" as a protection for human research participants.

Authors:  Carol Levine; Ruth Faden; Christine Grady; Dale Hammerschmidt; Lisa Eckenwiler; Jeremy Sugarman
Journal:  Am J Bioeth       Date:  2004       Impact factor: 11.229

Review 6.  Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span.

Authors:  Ricardo Azziz; Catherine Marin; Lalima Hoq; Enkhe Badamgarav; Paul Song
Journal:  J Clin Endocrinol Metab       Date:  2005-06-08       Impact factor: 5.958

7.  Professional integrity in clinical research.

Authors:  F G Miller; D L Rosenstein; E G DeRenzo
Journal:  JAMA       Date:  1998-10-28       Impact factor: 56.272

8.  Gradations of researchers' obligation to provide ancillary care for HIV/AIDS in developing countries.

Authors:  Henry S Richardson
Journal:  Am J Public Health       Date:  2007-09-27       Impact factor: 9.308

9.  Patients' attitudes and preferences about participation and recruitment strategies in clinical trials.

Authors:  Amit Sood; Kavita Prasad; Laveena Chhatwani; Eri Shinozaki; Stephen S Cha; Laura L Loehrer; Dietlind L Wahner-Roedler
Journal:  Mayo Clin Proc       Date:  2009-03       Impact factor: 7.616

Review 10.  The clinical investigator-subject relationship: a contextual approach.

Authors:  David B Resnik
Journal:  Philos Ethics Humanit Med       Date:  2009-12-03       Impact factor: 2.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.